Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Communication Services Companies: trivago (TRVG) and Meta Platforms (META)

Tipranks - Fri May 2, 2025

Analysts have been eager to weigh in on the Communication Services sector with new ratings on trivago (TRVGResearch Report) and Meta Platforms (METAResearch Report).

Protect Your Portfolio Against Market Uncertainty

trivago (TRVG)

In a report released today, Tom White from D.A. Davidson maintained a Hold rating on trivago. The company’s shares closed last Wednesday at $4.16.

According to TipRanks.com, White is a 2-star analyst with an average return of 0.4% and a 40.5% success rate. White covers the Technology sector, focusing on stocks such as Uber Technologies, Yext, and Lyft. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for trivago with a $4.23 average price target, representing a 4.2% upside. In a report issued on April 28, UBS also maintained a Hold rating on the stock with a $3.40 price target.

See the top stocks recommended by analysts >>

Meta Platforms (META)

In a report released today, Gil Luria from D.A. Davidson reiterated a Buy rating on Meta Platforms, with a price target of $650.00. The company’s shares closed last Wednesday at $549.00.

According to TipRanks.com, Luria is a 4-star analyst with an average return of 7.3% and a 41.3% success rate. Luria covers the Technology sector, focusing on stocks such as SoundHound AI, Inc Class A, Palantir Technologies, and ZoomInfo Technologies. ;'>

Meta Platforms has an analyst consensus of Strong Buy, with a price target consensus of $684.00, representing a 27.0% upside. In a report issued on April 16, Cantor Fitzgerald also maintained a Buy rating on the stock with a $624.00 price target.

Read More on TRVG:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.